MedPath

se of special yoghurt to improve vitamin B12 status.

Not Applicable
Completed
Registration Number
CTRI/2015/04/005703
Lead Sponsor
Department of Biotechnology New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

Age between 18-50yrs

-Willing to consent and participate in the study

Exclusion Criteria

-Known allergy of milk and milk products

-Severely B12 deficient (less than 100 pmol/L)

-Anemia (Hemoglobin less than 7 g/ 100 ml)

-Pregnant or lactating or planning for pregnancy in the study period

-Already taking supplements containing vitamin B12 for 15 or more days

-On treatment with drugs known to impair the absorption or utilization of B12 (eg phenytoin, antacids, metformin)

-Medical conditions interfering with B12 absorption and utilization; chronic gastro-intestinal disease

-Chronic illnesses preventing participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
plasma vitamin B12 concentrationsTimepoint: baseline and 120 days post intervention
Secondary Outcome Measures
NameTimeMethod
/ATimepoint: N/A
© Copyright 2025. All Rights Reserved by MedPath